BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2677632)

  • 21. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
    Borden EC
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma.
    VanderMolen LA; Steis RG; Duffey PL; Foon KA; Smith JW; Clark JW; Conlon K; Stevenson HC; Urba WJ; Hartmann LC
    J Natl Cancer Inst; 1990 Feb; 82(3):235-8. PubMed ID: 2296053
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary enzyme excretion during treatment of malignancies with human recombinant alpha-2 interferon.
    Metz-Kurschel U; Kurschel E; Niederle N; Scheulen ME; Graben N
    Nephrol Dial Transplant; 1987; 2(6):515-9. PubMed ID: 2894618
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of lymphoma of a higher stage of malignancy treated with cytostatics and interferon].
    Cieślińska A
    Pol Tyg Lek; 1988 Jul; 43(28):917-8. PubMed ID: 3247263
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant IFN-alpha in lymphomas.
    Ziegler-Heitbrock HW; Thiel E
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):213S-215S. PubMed ID: 1701808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azothymidine and interferon-alpha are active in AIDS-associated small non-cleaved cell lymphoma but not large-cell lymphoma.
    Harrington WJ; Cabral L; Cai JP; Chan-A-Sue S; Wood C
    Lancet; 1996 Sep; 348(9030):833. PubMed ID: 8814017
    [No Abstract]   [Full Text] [Related]  

  • 27. Inroads in the therapy of indolent lymphomas: exploiting biological insights.
    McLaughlin P
    Cancer Invest; 1999; 17(1):73-86. PubMed ID: 10999051
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interferon and tactivin in the treatment program for non-Hodgkin's lymphomas in children during remission].
    Makhonova LA; Kiselev AV; Gordina GA; Kadagidze ZG
    Vopr Onkol; 1995; 41(2):80-1. PubMed ID: 7483451
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma].
    Wörmann B; Unterhalt M; Hiddemann W
    Internist (Berl); 1993 Feb; 34(2):132-8. PubMed ID: 8454426
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon in the treatment of multiple myeloma and non Hodgkins lymphoma.
    Smruti BK; Nair R; Gopal R
    J Assoc Physicians India; 1995; Suppl 3():33-7. PubMed ID: 8773120
    [No Abstract]   [Full Text] [Related]  

  • 31. Biologic therapies for low-grade lymphomas.
    Parkinson DR; Sznol M; Cheson BD
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):111-7. PubMed ID: 8211201
    [No Abstract]   [Full Text] [Related]  

  • 32. Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B hepatitis: interim results of a randomized controlled open study.
    Weiland O; Schvarcz R; Wejstål R; Norkrans G; Foberg U; Frydén A
    Scand J Infect Dis; 1989; 21(2):127-32. PubMed ID: 2499037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant alpha-2a interferon in the treatment of refractory anemia with excess of blasts.
    Rossi G; Pagetto A; Boverio R; Montanaro G
    Haematologica; 1990; 75(1):97-8. PubMed ID: 2338298
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-2 interferon therapy for cutaneous T cell lymphoma.
    Tulli A
    J Am Acad Dermatol; 1989 Apr; 20(4):686-7. PubMed ID: 2785538
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferon.
    Martino S; Ratanatharathorn V; Karanes C; Samal BA; Sohn YH; Rudnick SA
    J Cancer Res Clin Oncol; 1987; 113(4):376-8. PubMed ID: 3597523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
    Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
    Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant alpha-2a interferon in HIV-associated myelodysplasia.
    Garavelli PL
    Haematologica; 1988; 73(6):547. PubMed ID: 3148520
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic non-A non-B hepatitis treated with interferon].
    Bjøro K; Schrumpf E; Elgjo K; Nordgård K
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1346-8. PubMed ID: 2111053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The alpha interferons: clinical overview.
    Spiegel RJ
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):1-12. PubMed ID: 3296210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
    Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.